65,437 trials
Chronic Hepatitis C
Primary: Percentage of Participants With Sustained Virologic Response (SVR) 12 Weeks After Discontinuation of Therapy (SVR12) — 92.9; 96.2; 74.1; 100.0 percentage of participants
Prostate Cancer · Psychosocial Effects of Cancer and Its Treatment · Radiation Toxicity
Primary: Percentage of Patients With Reduction From Baseline to the One-year EPIC Bowel Domain Score That Exceeds 5 Points — 30.1; 28.0 percentage of participants — p=0.19
Diabetes · Diabetes Mellitus, Type 2
Primary: Time From Randomisation to First Occurrence of a Major Adverse Cardiovascular Event (MACE): Cardiovascular Death, Non-fatal Myocardial Infarction, or Non-fatal Stroke…
Pompe Disease
Primary: Safety Assessments of the rAAV1-CMV-GAA (Study Agent), Changes Post Study Agent Administration. — 40,031; 29,638; 5,509,882; 1,907,161 mU/mL
Hyperparathyroidism, Secondary
Primary: Number of Participants With Adverse Events — 768; 436; 287; 4 participants
Prevention of CMV Infection or Disease
Primary: Percentage of Participants With Clinically-significant CMV Infection up to Week 24 Post-transplant — 37.5; 60.6 Percentage of participants — p=<0.0001
Tobacco Use Disorder
Primary: Feasibility of Progesterone as a Relapse Prevention Intervention for Postpartum Women With Pre-conception Smoking: Adherence to Treatment — 84.5; 76.0 doses of medication
Hernia, Inguinal
Primary: Mean Operative Time — 69; 84; 40; 66 minutes — p=0.17
Diabetes · Weight Loss · Physical Function
Primary: Short Physical Performance Battery (SPPB) Score — 10.1; 10.0 Score on a scale
Polycystic Ovary Syndrome
Primary: Peripheral Insulin Sensitivity at Baseline and 6 Months. — 2.2; 2.1; 3.2; 2.0 mg/kg/min per uU/mL
Vertebrobasilar Insufficiency · Ischemic Attack, Transient · Cerebrovascular Disorder
Primary: Fatal and Nonfatal Ischemic Stroke in the Vertebrobasilar Territory — 72 Participants
Congenital Bleeding Disorder · Haemophilia B
Primary: Incidence of Inhibitory Antibodies Against Coagulation Factor IX (FIX) Defined as Titre Above or Equal to 0.6 Bethesda Units (BU) — 0; 0 Participants
Congestive Heart Failure
Primary: Urine Output — 1636; 1515 mL
Albinism · Vision Loss
Primary: Absolute Mean Change in Iris Pigmentation on an 8-point Iris Transillumination Scale at 12 Months as Compared to Baseline. Participants Left and Right Eyes Will be…
Diabetes Mellitus · Obesity · Paraplegia
Primary: Change in % Body Fat — -1.83; -1.68 Percent Body Fat — p=>0.05